On Monday, we were first to report that a study of green coffee bean extract for weight loss touted on the Dr. Oz Show had been retracted.
That story has been widely picked up by the media, including The Washington Post, which yesterday reported that the show had posted a statement about the development: Continue reading Dr. Oz: Following green coffee bean diet retraction, site scrubbed, “further study is needed”
Two authors of a 2012 paper sponsored by a company that made grand claims about green coffee bean extract’s abilities to help people lose weight have retracted it. The study was cited by The Dr. Oz Show, and last month it cost the company a $3.5 million settlement with the Feds.
Here’s the notice for “Randomized, double-blind, placebo-controlled, linear dose, crossover study to evaluate the efficacy and safety of a green coffee bean extract in overweight subjects,” a paper originally published in Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy: Continue reading Authors retract green coffee bean diet paper touted by Dr. Oz
The Journal of Neuroscience hasn’t changed its policy of not explaining retractions if authors don’t want to, as this October 8 notice attests.
Here’s the notice for “Coordinated Regulation of Hepatic Energy Stores by Leptin and Hypothalamic Agouti-Related Protein:” Continue reading Journal of Neuroscience still won’t explain author-initiated retractions
The Journal of the American Academy of Dermatology has issued an expression of concern about a 2012 article reporting the experience of military burn unit treating a rare ailment called toxic epidermal necrolysis.
According to the notice, which is behind a paywall (for shame!), the paper appears to have overstated the number of cases the hospital itself has treated of the life-threatening condition: Continue reading Journal expresses concerns over “possible data irregularities” in paper from Army medical center docs
Gizem Donmez, a neuroscientist who has retracted two papers from Cell and the Journal of Biological Chemistry, is no longer in her position at Tufts University, Retraction Watch has learned.
A Tufts spokesperson confirmed the news for us yesterday: Continue reading Neuroscientist who threatened to sue Science-Fraud.org, retracted two papers is out at Tufts
A paper published in Measurement in Physical Education and Exercise Science has been retracted for statistical and typographical mistakes.
Here’s the notice for “Comparing Measurement Error Between Two Different Methods of Measurement of Various Magnitudes”: Continue reading How meta: Paper on errors retracted for “too many stupid mistakes”
A third study of GcMAF, a protein being used to treat a variety of conditions from AIDS to autism to cancer, all without the blessing of health agencies, has been retracted.
Here’s the notice in Cancer Immunology, Immunotherapy for “Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophage-activating factor, GcMAF:” Continue reading Yet another study of widely touted cancer “cure” retracted
Phyllis Wise, the chancellor of the University of Illinois and an obstetrics researcher, has called for a massive correction of a 2006 paper in Neuroscience for work she appears to have tried to pass off as having been previously unpublished — but which wasn’t.
The article, “Estrogen therapy: Does it help or hurt the adult and aging brain? Insights derived from animal models,” has been cited 47 times, according to Thomson Scientific’s Web of Knowledge.
And it had caught also the attention of readers on PubPeer, who noted that: Continue reading U. Illinois chancellor earns mega-correction for duplicate publication
A little more than a month after removing a highly criticized article that claimed the measles-mumps-rubella (MMR) vaccine increased the risk of autism in African American boys, Translational Neurodegeneration has officially retracted the paper.
Here’s the notice, dated yesterday: Continue reading Journal makes it official, retracting controversial autism-vaccine paper
The authors of a 1997 paper on macular degeneration have lost the article after readers noticed uncanny similarities with a 1996 publication from several of the same authors.
The retracted article, “Radiation therapy for macular degeneration: Technical considerations and preliminary results,” appeared in the International Journal of Radiation Oncology*Biology*Physics — otherwise known as the “Red Journal.” The first author, Luther W. Brady, is a leading U.S. oncologist.
According to the retraction notice: Continue reading Double dipping on trial data topples 17-year-old macular degeneration article